Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine in Diarrhea-predominant IBS
NCT01327300Phase 2Completed
- Sponsor
- University of Florida
- Start
- Mar 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Salcrozine in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by University of Florida. Started Mar 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01327300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327300.